Penicillin V Potassium
Cat. No.：YN251190
| 产品名称: | Penicillin V Potassium |
| CAS No.: | 132-98-9 |
| Chemical Name: | (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, monopotassium salt |
| Synonyms: | Phenoxymethylpenicillin potassium salt |
| 分子量: | 388.48 |
| 分子式: | C₁₆H₁₇KN₂O₅S |
| SMILES: | O=C(O[K])[C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(COC3=CC=CC=C3)=O)N1C2=O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Penicillin V Potassium (Phenoxymethylpenicillin potassium salt) 是一种口服活性抗生素。Penicillin V Potassium 可抑制链球菌，艰难梭菌和金黄色葡萄球菌的生长，可用于中耳炎，鼻窦炎，咽炎和扁桃体炎的研究。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Kamme, C., and Petersson, A.C.In vitro effect on group A streptococci of loracarbef versus cefadroxil, cefaclor and penicillin VScand. J. Infect. Dis.25(1),37-42(1993)
Norén, T., Alriksson, I., Akerlund, T., et al.In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in SwedenClin. Microbiol. Infect.16(8),1104-1110(2010)
Overbosch, D., Mattie, H., and Van Furth, R.Comparative pharmacodynamics and clinical pharmacokinetics of phenoxymethylpenicillin and pheneticillinBr. J. Clin. Pharmacol.19(5),657-668(1985)
Powell, H.M., and Culbertson, C.G.Effectiveness of phenoxymethyl penicillin V, and sodium penicillin G against hemolytic Streptococcus infection in white miceProc. Soc. Exp. Biol. Med.90(1),186-187(1955)
Hermansson, A., Prellner, K., and Hellström, S.Prevention of experimental acute otitis media with penicillin VActa Otolaryngol.109(1-2),119-123(1990)
